Pharma Industry News From Turkey
Turkey's Foreign Trade Undersecretariat has said that prioritycountries for Turkish pharmaceutical exports in 1997 include Georgia, Kazakhstan, Azerbaijan, Vietnam, Indonesia, Malaysia and Spain, as well as North Africa and the Middle East, reports EBA.
EBA also notes that Turkish and Nigerian government officials have agreed to increase cooperation between the two countries in the production and trading of pharmaceuticals and medical equipment, during talks in Lagos, Nigeria, at the end of December.
And the Turco-Indian Business Council has said there are good opportunities for increased cooperation between Turkish and Indian companies in medicines production. They could also set up joint ventures within the European Union and the Central Asian Republics, it proposed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze